[1]
Rezaeizadeh, H. et al. 2022. Assessing Honey Jell® as a Treatment for Reducing Cancer-Related Fatigue in Breast Cancer Patients Undergoing Radiotherapy: Double Blind Phase III Clinical Trial: Honey Jell for Reducing CRF. Archives of Breast Cancer. 9, 3 (Mar. 2022), 358–363. DOI:https://doi.org/10.32768/abc.202293358-363.